The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.2K citations · Full text

Solid Organ Transplantation, Immunology, Pathology +17

Spirometric Reference Values from a Sample of the General U.S. Population

John Hankinson, John Odencrantz, Kathleen B. Fedan · American Journal of Respiratory and Critical Care Medicine · 1999 · 4.2K citations

Physical Activity, Population Science, Anthropometric Indicator +19

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.8K citations · Full text

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

Erika Assarsson, Martin Lundberg, Göran Holmquist et al. · PLoS ONE · 2014 · 1.8K citations · Full text

Multiplex Technology, Engineering, Laboratory Immunology +27

Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

Stephanie J. Lee, E. Francis Cook, Robert J. Soiffer et al. · Biology of Blood and Marrow Transplantation · 2002 · 238 citations · Full text